Thursday, July 9, 2009

Bipolar Home>
News>
FDA adds suicide warning to anti-seizure drugs

Font size
- A
- A
- A
Email This

Bookmark

Save

Exclusive savings on ADHD products and much, much more! Start saving today!

FDA adds suicide warning to anti-seizure drugs

(WBOC-TV 16) UPDATED 2008-12-16

The U.S. Food and Drug Administration (FDA) has added a label warning about an increased suicide risk to anti-seizure drugs such as Klonopin, Dilantin, and Topamax. The FDA's move comes in response to a recommendation by one of its expert advisory panels last summer, but it stops short of the strongest "black box" warning label. FDA officials say patients taking these medications should be monitored for signs of depression, for suicidal thoughts or behavior, or for any other unusual changes in mood or behavior. Anti-seizure medicines are used to treat a number of conditions, including epilepsy, migraines, and bipolar disorder. Read full story >

See all Bipolar News

Related: Dilantin, Topamax, klonopin

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on BipolarConnect.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.